Published in Cancer Res Treat on December 31, 2005
Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat (2013) 7.11
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat (2015) 6.31
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat (2014) 5.97
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat (2012) 5.07
Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat (2009) 5.01
Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci (2007) 4.36
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat (2011) 4.21
Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci (2010) 3.79
Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci (2009) 2.61
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013. Cancer Res Treat (2016) 2.31
Prediction of cancer incidence and mortality in Korea, 2015. Cancer Res Treat (2015) 1.99
National cancer incidence for the year 2002 in Korea. Cancer Res Treat (2007) 1.88
Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res Treat (2012) 1.75
Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. World J Surg (2010) 1.65
The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci (2009) 1.65
Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat (2013) 1.61
Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010. J Gynecol Oncol (2013) 1.56
Prediction of cancer incidence and mortality in Korea, 2014. Cancer Res Treat (2014) 1.55
Increasing trend of colorectal cancer incidence in Korea, 1999-2009. Cancer Res Treat (2012) 1.43
Survival of korean adult cancer patients by stage at diagnosis, 2006-2010: national cancer registry study. Cancer Res Treat (2013) 1.37
Trends in gynecologic cancer mortality in East Asian regions. J Gynecol Oncol (2014) 1.29
Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc (2010) 1.29
Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One (2012) 1.26
Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc (2012) 1.25
Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival. J Korean Med Sci (2007) 1.23
CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer (2006) 1.17
The role of serum pepsinogen in the detection of gastric cancer. Gut Liver (2010) 1.10
Radiation exposure and cancer incidence in a cohort of nuclear power industry workers in the Republic of Korea, 1992-2005. Radiat Environ Biophys (2009) 1.08
Prediction of Cancer Incidence and Mortality in Korea, 2016. Cancer Res Treat (2016) 1.07
Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005-2009. PLoS One (2012) 1.06
Prediction of cancer incidence and mortality in Korea, 2011. Cancer Res Treat (2011) 1.06
Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study. Br J Cancer (2007) 1.05
Cancer incidence and survival among adolescents and young adults in Korea. PLoS One (2014) 1.01
Factors associated with use of gastric cancer screening services in Korea. World J Gastroenterol (2009) 0.97
An updated nationwide epidemiology of primary brain tumors in republic of Korea. Brain Tumor Res Treat (2013) 0.96
Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: its usefulness according to histological type. BMC Gastroenterol (2010) 0.95
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014. Cancer Res Treat (2017) 0.93
Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.92
Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea. Int J Colorectal Dis (2007) 0.92
Epidemiologic characteristics of cervical cancer in Korean women. J Gynecol Oncol (2014) 0.92
Current approaches to gastric cancer in Korea. Gastrointest Cancer Res (2008) 0.90
Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health (2010) 0.90
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy. BMC Cancer (2011) 0.90
Proposal for Creating a Guideline for Cancer Registration of Microinvasive Tumors of the Breast and Ovary (II). Korean J Pathol (2012) 0.89
Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. Int J Cancer (2014) 0.89
A case report of lung cancer in a horse trainer caused by exposure to respirable crystalline silica: an exposure assessment. Saf Health Work (2013) 0.87
Clinical features of colorectal cancer detected by the national cancer screening program. J Korean Soc Coloproctol (2010) 0.87
Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development. Virol J (2010) 0.86
Efficacy and safety of endoscopic submucosal dissection for early gastric cancer in patients with comorbid diseases. Gut Liver (2010) 0.85
Age and sex interactions in gastric cancer incidence and mortality trends in Korea. Gastric Cancer (2014) 0.85
Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer. Cancer Res Treat (2007) 0.85
Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage Cancers and Hormone Receptor Positive/HER2 Negative Subtypes: A Nationwide Registry-Based Study. J Breast Cancer (2015) 0.84
Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea. Gut Liver (2010) 0.83
A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer. Br J Cancer (2007) 0.82
What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea? World J Gastroenterol (2009) 0.81
Trends in the aggressiveness of end-of-life care for Korean pediatric cancer patients who died in 2007-2010. PLoS One (2014) 0.81
Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study. PLoS One (2015) 0.81
Hepatitis B vaccinations among Koreans: Results from 2005 Korea National Cancer Screening Survey. BMC Infect Dis (2009) 0.80
Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010). PLoS One (2015) 0.80
Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control. J Cancer Epidemiol (2011) 0.80
Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012. Blood Res (2015) 0.79
Incidence and Treatment Pattern of Extremity Soft Tissue Sarcoma in Korea, 2009-2011: A Nationwide Study Based on the Health Insurance Review and Assessment Service Database. Cancer Res Treat (2015) 0.79
Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012. J Gynecol Oncol (2015) 0.79
Combined effects of smoking and bilirubin levels on the risk of lung cancer in Korea: the severance cohort study. PLoS One (2014) 0.79
Trends in Thyroid Cancer Incidence in Korean Children (1999-2012) Based on Palpation and Nonpalpation Detection Methods. Eur Thyroid J (2015) 0.78
Gastric cancer and family history. Korean J Intern Med (2016) 0.78
Incidence of primary spinal cord, spinal meninges, and cauda equina tumors in Korea, 2006-2010. Cancer Res Treat (2014) 0.78
A comparison of prostate cancer detection rates by 12 or 6 core biopsy at different prostate-specific antigen densities in Korean men. World J Urol (2008) 0.77
The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. BMC Gastroenterol (2014) 0.77
Evaluating adherence to recommended diets among cancer patients. Support Care Cancer (2011) 0.76
Prediction of Cancer Incidence and Mortality in Korea, 2017. Cancer Res Treat (2017) 0.76
Weekly low-dose docetaxel for salvage chemotherapy in pretreated elderly or poor performance status patients with non-small cell lung cancer. J Korean Med Sci (2008) 0.75
Incidence and Survival of Childhood Cancer in Korea. Cancer Res Treat (2016) 0.75
An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population. Cancer Res Treat (2011) 0.75
Gastric Cancer Associated Genes Identified by an Integrative Analysis of Gene Expression Data. Biomed Res Int (2017) 0.75
Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea. J Korean Med Sci (2016) 0.75
An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea, 2013. Brain Tumor Res Treat (2017) 0.75
Trends and Age-Period-Cohort Effects on the Incidence and Mortality Rate of Cervical Cancer in Korea. Cancer Res Treat (2016) 0.75
Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012. Cancer Res Treat (2016) 0.75
Disparities by Age, Sex, Tumor Stage, Diagnosis Path, and Area-level Socioeconomic Status in Survival Time for Major Cancers: Results from the Busan Cancer Registry. J Korean Med Sci (2017) 0.75
Prediagnosis Body Mass Index and Risk of Secondary Primary Cancer in Male Cancer Survivors: A Large Cohort Study. J Clin Oncol (2016) 0.75
Prevalence and survival prognosis of prostate cancer in patients with end-stage renal disease: a retrospective study based on the Korea national database (2003-2010). Oncotarget (2017) 0.75
Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033. PLoS One (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Genetic pathways to glioblastoma: a population-based study. Cancer Res (2004) 8.87
A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet (2009) 7.65
Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat (2013) 7.11
Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med (2012) 5.87
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat (2012) 5.07
Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat (2009) 5.01
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat (2011) 4.21
Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci (2010) 3.79
Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis (2013) 3.67
Prolongation of the period between biopsy and EMR can influence the nonlifting sign in endoscopically resectable colorectal cancers. Gastrointest Endosc (2008) 3.05
2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res Treat (2004) 2.90
Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis (2004) 2.63
Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci (2009) 2.61
Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22
Gastric cancer in Japan--honing treatment, seeking causes. N Engl J Med (2008) 2.18
The spread of pandemic H1N1 2009 by age and region and the comparison among monitoring tools. J Korean Med Sci (2010) 2.00
National cancer incidence for the year 2002 in Korea. Cancer Res Treat (2007) 1.88
Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg (2006) 1.83
A nationwide survey on the prevalence of intestinal parasitic infections in the Republic of Korea, 2004. Korean J Parasitol (2009) 1.81
Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res Treat (2012) 1.75
High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island. Cancer Epidemiol Biomarkers Prev (2004) 1.74
Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea. BMC Cancer (2014) 1.71
Sensitivity Analysis of the Parameters of Korea's Pandemic Influenza Preparedness Plan. Osong Public Health Res Perspect (2011) 1.70
Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virus. Pediatr Pulmonol (2010) 1.70
ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res (2003) 1.64
Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. Cancer Causes Control (2010) 1.61
Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res Treat (2013) 1.61
Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea. Cancer (2014) 1.60
Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control (2003) 1.59
Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010. J Gynecol Oncol (2013) 1.56
Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol (2012) 1.56
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.53
Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg (2008) 1.51
Data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry. Ann Coloproctol (2013) 1.49
Feasibility of laparoscopic techniques as the surgical approach of choice for primary colorectal cancer: an analysis of 570 consecutive cases. Surg Endosc (2008) 1.48
Neonatal hair nicotine levels and fetal exposure to paternal smoking at home. Am J Epidemiol (2008) 1.48
Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol (2006) 1.44
Increasing trend of colorectal cancer incidence in Korea, 1999-2009. Cancer Res Treat (2012) 1.43
Relative and absolute risks of cigarette smoking on major histologic types of lung cancer in Korean men. Cancer Epidemiol Biomarkers Prev (2005) 1.41
Milestones in history of adult vaccination in Korea. Clin Exp Vaccine Res (2012) 1.41
Timeliness of national notifiable diseases surveillance system in Korea: a cross-sectional study. BMC Public Health (2009) 1.38
Characteristics and survival of korean anal cancer from the Korea central cancer registry data. Ann Coloproctol (2013) 1.38
Survival of korean adult cancer patients by stage at diagnosis, 2006-2010: national cancer registry study. Cancer Res Treat (2013) 1.37
Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res (2004) 1.37
Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World J Gastroenterol (1999) 1.34
Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2006) 1.33
Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol (2003) 1.33
Trends in socioeconomic disparities in organized and opportunistic gastric cancer screening in Korea (2005-2009). Cancer Epidemiol Biomarkers Prev (2010) 1.30
Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc (2010) 1.29
Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q. Int J Cancer (2008) 1.28
Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene (2004) 1.24
Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol (2007) 1.23
Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas. Int J Colorectal Dis (2007) 1.23
Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers. Hum Genet (2003) 1.21
Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers. Clin Cancer Res (2005) 1.21
Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea. J Korean Med Sci (2010) 1.20
Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res (2005) 1.20
Epidemiology of Japanese encephalitis in South Korea, 2007-2010. Int J Infect Dis (2012) 1.20
National action plan for response to poliovirus importation. Osong Public Health Res Perspect (2011) 1.17
Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genet Cytogenet (2009) 1.15
A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology (2004) 1.15
Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009. PLoS One (2013) 1.14
Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum (2007) 1.13
Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar. Parasitol Res (2005) 1.11
Biology of SNU cell lines. Cancer Res Treat (2005) 1.11
Estimation of cancer deaths in Korea for the upcoming years. J Korean Med Sci (2002) 1.11
Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data. Int J Cancer (2008) 1.11
Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg (2010) 1.10
Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. J Clin Invest (2012) 1.10